Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Some alternative treatments for hair loss might work, but more research is needed.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Stem cells could be a better treatment for hair loss by reactivating dormant hair follicles.

White hairs often regrow in alopecia areata patches.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

miRNAs could help diagnose and treat gouty arthritis.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.